...
首页> 外文期刊>Southern Medical Journal >Amiodarone-induced thyrotoxicosis presenting as hypokalemic periodic paralysis.
【24h】

Amiodarone-induced thyrotoxicosis presenting as hypokalemic periodic paralysis.

机译:胺碘酮引起的甲状腺毒症,表现为低钾性周期性麻痹。

获取原文
获取原文并翻译 | 示例
           

摘要

Thyroid disorder is a well-recognized side effect of amiodarone therapy. Thyrotoxicosis is less common than hypothyroidism. Hypokalemic periodic paralysis is one manifestation of thyrotoxicosis, and is more often seen in Oriental and Latin American men than in other demographic groups. This phenomenon, however, has not been previously described in thyrotoxicosis due to amiodarone usage. We describe a case of amiodarone-induced thyrotoxicosis in a 34-year-old man who presented with sudden lower extremity weakness, heat intolerance, and weight loss. Physical examination demonstrated fine tremors. Serum potassium level was 2.2 mEq/L on admission. Gastrointestinal and renal causes of potassium loss were excluded by history and physical examination. Further biochemical testing demonstrated abnormal thyroid function. The urinary potassium and serum bicarbonate, magnesium, and calcium levels were within normal limits. Lower extremity weakness resolved immediately after potassium replacement therapy. Methimazole therapy was initiated, and the patient was clinically euthyroid on discharge.
机译:甲状腺疾病是胺碘酮疗法公认的副作用。甲状腺毒症比甲状腺功能减退症少见。低钾性周期性麻痹是甲状腺毒症的一种表现,在东方人和拉丁美洲人中比在其他人群中更常见。然而,由于使用了胺碘酮,这种现象在甲状腺毒症中尚未被描述。我们描述了一个胺碘酮引起的甲状腺毒症的病例,该患者在34岁的男性患者中突然出现下肢无力,热不耐症和体重减轻。体格检查显示良好的震颤。入院时血清钾水平为2.2 mEq / L。病史和体格检查排除了胃肠道和肾脏引起钾丢失的原因。进一步的生化检查表明甲状腺功能异常。尿钾和血清碳酸氢根,镁和钙水平在正常范围内。补充钾后,下肢无力立即消失。开始使用甲乙咪唑治疗,出院时患者临床甲状腺功能正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号